Clal Insurance Enterprises Holdings Ltd lifted its stake in shares of Nova Ltd. (NASDAQ:NVMI – Free Report) by 0.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,205,865 shares of the semiconductor company’s stock after purchasing an additional 1,718 shares during the quarter. Nova comprises 3.1% of Clal Insurance Enterprises Holdings Ltd’s investment portfolio, making the stock its 8th biggest holding. Clal Insurance Enterprises Holdings Ltd owned about 3.79% of Nova worth $522,198,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently made changes to their positions in the company. Smartleaf Asset Management LLC acquired a new position in Nova during the 4th quarter worth approximately $29,000. Measured Wealth Private Client Group LLC acquired a new stake in Nova in the third quarter valued at approximately $40,000. CIBC Private Wealth Group LLC grew its stake in Nova by 75.7% in the third quarter. CIBC Private Wealth Group LLC now owns 130 shares of the semiconductor company’s stock valued at $42,000 after acquiring an additional 56 shares during the period. Caitong International Asset Management Co. Ltd increased its holdings in shares of Nova by 2,042.9% during the third quarter. Caitong International Asset Management Co. Ltd now owns 150 shares of the semiconductor company’s stock valued at $48,000 after acquiring an additional 143 shares in the last quarter. Finally, TD Private Client Wealth LLC bought a new stake in shares of Nova during the fourth quarter valued at approximately $74,000. 82.99% of the stock is currently owned by institutional investors and hedge funds.
Nova Stock Up 4.6%
Shares of Nova stock opened at $453.10 on Wednesday. The company has a market cap of $14.40 billion, a PE ratio of 56.50, a price-to-earnings-growth ratio of 3.14 and a beta of 1.74. Nova Ltd. has a 52 week low of $232.73 and a 52 week high of $615.99. The business has a 50 day moving average price of $505.74 and a 200-day moving average price of $474.73.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on NVMI. Jefferies Financial Group increased their target price on Nova from $520.00 to $640.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. Morgan Stanley boosted their price target on shares of Nova from $494.00 to $540.00 and gave the company an “equal weight” rating in a research note on Monday, July 6th. Needham & Company LLC upped their price objective on shares of Nova from $500.00 to $640.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $600.00 price objective on shares of Nova in a research note on Tuesday, July 14th. Finally, Zacks Research cut shares of Nova from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 14th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $556.67.
Read Our Latest Report on NVMI
Insider Buying and Selling
In related news, Director Yaniv Garty sold 426 shares of the business’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $514.49, for a total transaction of $219,172.74. Following the transaction, the director directly owned 2,038 shares in the company, valued at approximately $1,048,530.62. The trade was a 17.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eitan Oppenhaim sold 1,504 shares of the company’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $519.48, for a total transaction of $781,297.92. Following the completion of the sale, the director directly owned 6,668 shares of the company’s stock, valued at $3,463,892.64. The trade was a 18.40% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,798 shares of company stock valued at $4,125,266 in the last 90 days. Insiders own 1.00% of the company’s stock.
Nova Profile
Nova Measuring Instruments Ltd (NASDAQ: NVMI) develops and supplies advanced metrology and process control systems for the semiconductor manufacturing industry. The company’s core product line includes spectroscopic ellipsometry and scatterometry tools designed to measure film thickness, critical dimensions, overlay alignment and other key parameters that drive yield and performance in integrated circuit fabrication.
Founded in 1993 and headquartered in Rehovot, Israel, Nova Measuring Instruments has established itself as a critical partner to leading semiconductor foundries and device manufacturers.
Featured Stories
- Five stocks we like better than Nova
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Nova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nova and related companies with MarketBeat.com's FREE daily email newsletter.
